Comprehensive genomic profiling service for haematological malignancies and sarcomas; to guide diagnosis, prognosis and treatment selection and personalise patients' treatment plans.1-3
This site is not intended to provide medical advice and/or treatment guidance. It is produced by Roche as the licensed distributor of Foundation Medicine products outside of the US.
Please select an option:
Please note that you are now leaving www.foundationmedicine.my
FoundationOne Heme comprehensively analyses the cancer genome to identify clinically relevant genomic alterations in haematological malignancies and sarcomas.1-2
A clear, in-depth report supports your clinical decision-making by providing insights on the genomic profile of your patient as well as associated targeted therapies, immunotherapies and relevant clinical trials. The report also highlights important disease relevant genes with no reportable alterations identified and genomic alterations associated with potential resistance to therapy, to help rule out ineffective treatment.23
In Malaysia, accepted specimen types is FFPE block or slides. FoundationOne Heme is available in Malaysia for Sarcomas with specimen type in the form of FFPE block or slides. As blood and bone marrow aspirates for haematological malignancies must be received the day after collection for optimal analysis27, Malaysia may not be able to offer the FoundationOne Heme testing for haematological malignancies at this moment. We are working to make FoundationOne Heme more broadly available.
"Base substitutions, insertions or deletions, copy number alterations and gene rearrangements.
†Peripheral blood and bone marrow aspirate must be received the day after collection for optimal analysis as sensitivity of detection may degrade with time. Samples arriving later will result in a Qualified Report. FFPE block or slides are also accepted.
GIST, gastrointestinal stromal tumours. FFPE, formalin-fixed paraffin-embedded. MSI, microsatellite instability. RMS, rhabdomyosarcoma. TMB, tumour mutational burden.